SCHEMBL8485120

SCHEMBL8485120

CCCCN(CCC)C(=O)C1c2ccccc2-c2cccc(N3CCC(N4Cc5ccccc5C4)CC3)c21

nearest known ligand 0.36

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
▸ TSHR P16473 2/20 0.36
▸ MEN1 O00255 1/20 0.36
▸ KMT2A Q03164 1/20 0.36
▸ SMN1; SMN2 Q16637 1/20 0.36
▸ NPSR1 Q6W5P4 1/20 0.36
▸ DRD2 P14416 2/20 0.35
▸ HTR1A P08908 1/20 0.35
▸ HTR2A P28223 1/20 0.35
▸ OPRM1 P35372 1/20 0.34
▸ OPRL1 P41146 1/20 0.34
▸ BCL2 P10415 4/20 0.34
▸ BAD Q92934 1/20 0.34
▸ P2RX1 P51575 2/20 0.34
▸ P2RX4 Q99571 2/20 0.34
▸ P2RX3 P56373 1/20 0.34
▸ OPRK1 P41145 1/20 0.34
▸ NAMPT P43490 1/20 0.33
▸ BCHE P06276 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8668070 0.95 MEN1 (0.35) TSHRMEN1KMT2ASMN1; SMN2NPSR1
SCHEMBL8503791 0.91 TSHR (0.37) TSHRMEN1KMT2ASMN1; SMN2NPSR1
SCHEMBL8675063 0.86 L3MBTL1 (0.42) TSHRMEN1KMT2ASMN1; SMN2NPSR1
SCHEMBL8480927 0.85 NPSR1 (0.41) TSHRMEN1KMT2ASMN1; SMN2NPSR1
SCHEMBL8485591 0.84 NPY1R (0.41) TSHRMEN1KMT2ASMN1; SMN2NPSR1
SCHEMBL8479245 0.80 SCN1A (0.39) MEN1KMT2A
SCHEMBL8487923 0.78 SCN1A (0.38) MEN1KMT2A
SCHEMBL8480408 0.78 TMEM97 (0.38) TSHRMEN1KMT2ASMN1; SMN2NPSR1
SCHEMBL8485124 0.78 OPRK1 (0.33) DRD2HTR1AOPRK1
SCHEMBL8669685 0.78 NPSR1 (0.42) NPSR1DRD2NAMPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5739135-A PREVENTING OR TREATING ATHEROSCLEROSIS, PANCREATITIS SECONDARY TO HYPERTRIGLYCERIDEMIA, HYPERGLYCEMIA, OBESITY BRISTOL-MYERS SQUIBB COMPANY (US) 1998-04-14 — — US claimed
US-5883099-A TREATMENT OF ATHERSCLEROSIS, PANCREATITIS OBESITY OR HYPERGLYCEMIA BRISTOL-MYERS SQUIBB COMPANY (US) 1999-03-16 — — US disclosed
US-5739135-A PREVENTING OR TREATING ATHEROSCLEROSIS, PANCREATITIS SECONDARY TO HYPERTRIGLYCERIDEMIA, HYPERGLYCEMIA, OBESITY BRISTOL-MYERS SQUIBB COMPANY (US) 1998-04-14 — — US disclosed
Send feedback